Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT02242955
NA

Impact of a One-month Long Detoxification Diazepam Treatment on Early Alcohol Relapse

Sponsor: University Hospital, Lille

View on ClinicalTrials.gov

Summary

Alcohol-dependence is a medical condition that can lead to the occurrence of an alcohol withdrawal syndrome (AWS) in case of alcohol drinking cessation. Diazepam is the reference medication for preventing or treating AWS. The recommended average diazepam treatment duration is usually around one week, and this duration is generally not considered to impact the subsequent relapse rate in alcohol drinking. However, several previous studies have found that patients experienced frequent anxious symptoms during the weeks following detoxification. Such symptoms may foster early relapse in alcohol drinking. Furthermore, it has been suggested that this anxiety could pertain to late withdrawal symptoms. The DIAMA study hypothesizes that extending the diazepam detoxification treatment to one month can significantly reduce the cumulated relapse rate in alcohol drinking over the three following months.

Key Details

Gender

All

Age Range

18 Years - 60 Years

Study Type

INTERVENTIONAL

Enrollment

26

Start Date

2014-07

Completion Date

2016-07

Last Updated

2026-04-22

Healthy Volunteers

No

Conditions

Interventions

DRUG

Diazepam

40 mg per day.

Locations (2)

Department of Addiction Medicine

Lille, France

Outpatient Addiction Center "CSAPA - Le Pari"

Lille, France